期刊文献+

游泳运动与选择性雌激素受体调节剂(SERMs)干预去势大鼠骨放射免疫指标的实验研究 被引量:1

Swimming and selective estrogen receptor modulator(SERMs) intervention to ovarian rats ria index of bone
在线阅读 下载PDF
导出
摘要 目的:通过对去势大鼠血液放射免疫指标的比较,探讨游泳运动与选择性雌激素受体调节剂联合作用对去势大鼠骨代谢的影响。方法:将50只雌性SD大鼠随机分为5组:假手术组仅手术不切除卵巢,其余各组去卵巢造模,运动组、药物组及运动+药物组分别在去卵巢的基础上进行游泳训练和(或)灌胃选择性雌激素受体调节剂雷洛昔芬。8周后,比较各组大鼠血液放免指标(雌二醇E2、骨钙素BGP、降钙素CT、雌激素受体ER)的变化。结果与结论:1)去势早期对大鼠进行运动干预可抑制大鼠体质量的快速增加。2)与模型组相比,运动组,药物组,运动+药物组大鼠的除E2外的各项指标都显著优于模型组大鼠(P<0.05),部分特异性指标出现非常显著性差异(P<0.01),雌激素受体活性增强,骨量增加。3)模型组各项指标都与假手术组有显著性差别(P<0.05),骨代谢呈高转换型。说明游泳运动和/或SERMs均可在一定程度上改善各项骨代谢的血液放免指标,延缓骨丢失,抑制高转换型骨代谢率。以SERMs和运动联合作用效果最佳。 Objective:To investigate the combined efforts of swimming exercise and sports and selective estrogen receptor modulators(SERMs) by ria index and estrogen receptor,and probe into a better method which can preventand cure postmenopausal osteoporosis.Method:50 female SD rats were divided randomly into 5 teams.Take the exercise for the sport of swimming,and take Oral drug for the SERMs raloxifene category.The experiment will continue 8 weeks.Measure the ria index.Results:1) The research has successfully established rat transformational the osteoporotic model.2)Removal of the ovary early exercise interventions rats can inhibit the rapid increase weight bone metabolism,improve the blood of index.Conclusions:After 8 weeks,swimming exercise,SERMs taking,swimming exercise and SERMs can enhance the level of estrogen of Ovariectomized rats,improve the bone metabolism of blood indicators to some extent,retard bone loss,inhibit high conversion rate of bone metabolism.
作者 彭筱 代毅
出处 《山东体育学院学报》 CSSCI 北大核心 2011年第2期53-56,70,共5页 Journal of Shandong Sport University
关键词 绝经后骨质疏松 游泳 选择性雌激素受体调节剂 放免指标 postmenopausal osteoporosis swimming SERMs ria index
  • 相关文献

参考文献22

  • 1Albfight F, Smith PH, Rchardson AM. Postmenopausal osteopo- rosis :Its feature[ J ]. JAMA, 1941,116:2465 - 2476.
  • 2Hansdottir H, Franzson L, Prest wood K, et al. The effect of raloxifene on markers of bone turnover in olderw omen living in long term care facillities [J]. J Am Geriatr Soc, 2004, 52(5).
  • 3N akamura T, L iu J L, M orii H, et al. Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis [ J]. J B one n inern etab, 2006, 24 (5).
  • 4权金星,李茂欣.绝经后骨质疏松的分子机理研究进展[J].中华妇产科杂志,2000,35(12):754-756. 被引量:21
  • 5Giavaresi G, Fini M, Gnudi S, et al. The female distal epiphysis of ovariectomized rats as a site for study on osteoporosis : structural and mechanical evaluations [ J ]. Rheumatol, 2002,20 : 171 - 178.
  • 6Kalu DN. The ovariectomized rat model of postmenopausal bone loss [ J ]. Bone Miner, 1991,15 ( 3 ) : 175 - 191.
  • 7Faugere MC, Okamoto S, DeLuca HF,et al. Calcitriol corrects bone loss induced by oopborectomy in rats[ J]. Am J Physiol, 1986, 250 ( 1 ) : E35 - E38.
  • 8Tzukerman MT, Es ty A. Santiso--Mere D et al. Human estro- gen receptor transcriptional capacity is determined by both cellular and promoter context and medicated by two functionally distinct in- tra molecular regions [ J ]. Mol Endocrin, 1994, ( 1 ) :21 - 30.
  • 9Taranta A, Brama M. The Selective estrogen receptor modula- tor raloxifene regulates osteoclast and osteoblast activity in vitro [J]. Bone, 2002, 30:368-376.
  • 10Turner CH, Sato M, Bryant HU. Raloxifene preserves bone strength and bone mass in ovariectomized rats [ J ]. Endocrinology, 1994,135:2001 - 2005.

二级参考文献48

  • 1杨梅芳,李振甲,朱守荣,何绍贵,张玉娥,马三元,皇甫立云.骨钙素RIA试剂盒研制及其临床应用[J].中华核医学杂志,1994,14(3):167-169. 被引量:49
  • 2李朝阳,吴铁,李青南,林柏云,梁念慈,黄连芳,崔燎.蛇床子素对去卵巢大鼠近侧胫骨代谢影响的定量研究[J].药学学报,1996,31(5):327-332. 被引量:56
  • 31,Burger EH,van der Meer JWM,Nijweide PJ.Osteoclast formation from mononuclear phagocytes.role of bone-forming cells.J Cell Biol,1984,99:1901-1906.
  • 42,Takahashi N,Yamana M,Yoshiki S,et al.Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.Endocrinology,1988,122:1373-1380.
  • 53,Takahashi N,Udagawa N,Akatsu T,et al.Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells.Endocrinology,1991,128:1792-1796.
  • 64,Takahashi N,Udagawa N,Akatsu T,et al.Role of colony-stimulating factors in osteoclast development.J Bone Miner Res,1991,6:977-985.
  • 75,Fenton AJ,Martin TJ,Nicholson GC.Long-term culture of disaggregated rat osteoclasts:Inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrp(107-199).J Cell Physiol,1993,155:1-7.
  • 86,Jimi E,Nakamura I,Amano H,et al.Osteoclast function is activated by osteoblastic cell through a mechanism involving cell-to-cell contact.Endocrinology,1996,137:2187-2190.
  • 97,Takahashi N,Udagawa N,Suda T. A new member of tumor necrosis factor ligand family,ODF/OPGL/TRANCE/RANKL,regulates osteoclast differentiation and function.Biochem Biophys Res Commun,1999,256(3):449-455.
  • 108,Yamamoto M,Murakami T,Nishikawa M,et al.Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat.Endocrinology,1998,139(9):4012-4015.

共引文献48

同被引文献14

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部